Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022)
Precigen (PGEN) posted quarterly Liabilities from Discontinued Operations of 11448000.0 for Q2 2022, up 11123.53% year-over-year from N/an in Q2 2021, and down 10.92% quarter-over-quarter from 12851000.0 in Q4 2021.
Analysis
Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022) Analysis & Trends
Precigen (PGEN) has reported Liabilities from Discontinued Operations for 5 consecutive years, with 11448000.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Liabilities from Discontinued Operations rose 11123.53% year-over-year to 11448000.0; the TTM figure through Jun 2022 stood at 11448000.0 (up 11123.53% YoY), while the FY2021 annual figure was 12851000.0, down 8.51% from the prior year.
- Liabilities from Discontinued Operations retreated to 11448000.0 in Q2 2022 per PGEN's latest filing, from 12851000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 50538000.0 in Q4 2019 and bottomed at 102000.0 in Q2 2021.
- Historically, Liabilities from Discontinued Operations has averaged 14302285.71 across 5 years, with a median of 11448000.0 in 2022.
- Annual changes were most pronounced in 2020 — Liabilities from Discontinued Operations plunged 72.21% — and 2022, when it surged 11123.53%.
- Precigen's Liabilities from Discontinued Operations stood at 10958000.0 in 2018, then surged by 361.2% to 50538000.0 in 2019, then slumped by 72.21% to 14047000.0 in 2020, then slipped by 8.51% to 12851000.0 in 2021, then fell by 10.92% to 11448000.0 in 2022.
- Business Quant data shows PGEN's Liabilities from Discontinued Operations at 11448000.0 in Q2 2022, 12851000.0 in Q4 2021, and 102000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 11.45 Mn |
| Dec 31, 2021 | 12.85 Mn |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 172,000.00 |
| Dec 31, 2020 | 14.05 Mn |
| Dec 31, 2019 | 50.54 Mn |
| Dec 31, 2018 | 10.96 Mn |